Indian Journal of Microbiology

, Volume 59, Issue 1, pp 73–80 | Cite as

Prediction of MicroRNAs in the Epstein–Barr Virus Reveals Potential Targets for the Viral Self-Regulation

  • Victor Serrano-Solis
  • Angelica Cardoso Carlos
  • Vinicius Maracaja-Coutinho
  • Sávio Torres de FariasEmail author
Original Research Article


Studies involving miRNAs have opened discussions about their broad participation in viral infections. Regarding the Human gammaherpesvirus 4 or Epstein–Barr virus (EBV), miRNAs are important regulators of viral and cellular gene expression during the infectious process, promoting viral persistence and, in some cases, oncogenic processes. We identified 55 miRNAs of EBV type 2 and inferred the viral mRNA target to self-regulate. This data indicate that gene self-repression is an important strategy for maintenance of the viral latent phase. In addition, a protein network was constructed to establish essential proteins in the self-regulation process. We found ten proteins that work as hubs, highlighting BTRF1 and BSRF1 as the most important proteins in the network. These results open a new way to understand the infection by EBV type 2, where viral genes can be targeted for avoiding oncogenic processes, as well as new therapies to suppress and combat the persistent viral infection.


Epstein–Barr virus miRNA s Self-regulation 



This work was funded in part by grants from Comisión Nacional de Investigación Científica y Tecnológica (CONICYT), Chile: FONDECYT 10111620, FONDAP 15130011, PAI PAI79170021. ACC received a master degree fellowship from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil. VSS was a post doctorate fellowship from PNPD/CAPES.

Supplementary material

12088_2018_775_MOESM1_ESM.docx (22 kb)
Supplementary material 1 (DOCX 22 kb)


  1. 1.
    Lefkowitz EJ, Dempsey DM, Hendrickson RC, Orton RJ, Siddell SG, Smith DB (2018) Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV). Nucleic Acids Res 46:D708–D717. CrossRefPubMedGoogle Scholar
  2. 2.
    Cohen JI (2000) Epstein–Barr virus infection. N Engl J Med 343:481–492. CrossRefPubMedGoogle Scholar
  3. 3.
    Palser AL, Grayson NE, White RE, Corton C, Correia S, Ba Abdullah MM, Watson SJ, Cotton M, Arrand JR, Murray PG, Allday MJ, Rickinson AB, Young LS, Farrell PJ, Kellam P (2015) Genome diversity of Epstein–Barr virus from multiple tumor types and normal infection. J Virol 89:5222–5237. CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Houldcroft CJ, Kellam P (2015) Host genetics of Epstein–Barr virus infection, latency and disease: genetics of EBV infection. Rev Med Virol 25:71–84. CrossRefPubMedGoogle Scholar
  5. 5.
    Dolan A, Addison C, Gatherer D, Davison AJ, McGeoch DJ (2006) The genome of Epstein–Barr virus type 2 strain AG876. Virology 350:164–170. CrossRefPubMedGoogle Scholar
  6. 6.
    Buisson M, Morand P, Genoulaz O, Bourgeat M-J, Micoud M, Seigneurin J-M (1994) Changes in the dominant Epstein–Barr virus type during human immunodeficiency virus infection. J Gen Virol 75:431–437. CrossRefPubMedGoogle Scholar
  7. 7.
    Fruci D, Rota R, Gallo A (2017) The role of HCMV and HIV-1 microRNAs: processing, and mechanisms of action during viral infection. Front Microbiol 8:689. CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Skalsky RL, Cullen BR (2010) Viruses, microRNAs, and host interactions. Annu Rev Microbiol 64:123–141. CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Pfeffer S (2004) Identification of virus-encoded microRNAs. Science 304:734–736. CrossRefPubMedGoogle Scholar
  10. 10.
    Piedade D, Azevedo-Pereira J (2016) The role of microRNAs in the pathogenesis of herpesvirus infection. Viruses 8:156. CrossRefPubMedCentralGoogle Scholar
  11. 11.
    Arias-Carrasco R, Vásquez-Morán Y, Nakaya HI, Maracaja-Coutinho V (2018) StructRNAfinder: an automated pipeline and web server for RNA families prediction. BMC Bioinform. CrossRefGoogle Scholar
  12. 12.
    Burge SW, Daub J, Eberhardt R, Tate J, Barquist L, Nawrocki EP, Eddy SR, Gardner PP, Bateman A (2013) Rfam 11.0: 10 years of RNA families. Nucleic Acids Res 41:D226–D232. CrossRefPubMedGoogle Scholar
  13. 13.
    Nawrocki EP, Eddy SR (2013) Infernal 1.1: 100-fold faster RNA homology searches. Bioinformatics 29:2933–2935. CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Denman RB (1993) Using RNAFOLD to predict the activity of small catalytic RNAs. Biotechniques 15:1090–1095PubMedPubMedCentralGoogle Scholar
  15. 15.
    Ondov BD, Bergman NH, Phillippy AM (2011) Interactive metagenomic visualization in a web browser. BMC Bioinform 12:385. CrossRefGoogle Scholar
  16. 16.
    Mann M, Wright PR, Backofen R (2017) IntaRNA 2.0: enhanced and customizable prediction of RNA–RNA interactions. Nucleic Acids Res 45:W435–W439. CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Calderone A, Licata L, Cesareni G (2015) VirusMentha: a new resource for virus–host protein interactions. Nucleic Acids Res 43:D588–D592. CrossRefPubMedGoogle Scholar
  18. 18.
    Shannon P (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498–2504. CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Cai X, Schäfer A, Lu S, Bilello JP, Desrosiers RC, Edwards R, Raab-Traub N, Cullen BR (2006) Epstein–Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2:e23CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Skalsky RL (2017) Analysis of viral and cellular microRNAs in EBV-infected cells. Methods Mol Biol 1532:133–146CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Hooykaas MJ, Kruse E, Wiertz EJ, Lebbink RJ (2016) Comprehensive profiling of functional Epstein–Barr virus miRNA expression in human cell lines. BMC Genom 17:644. CrossRefGoogle Scholar
  22. 22.
    Choy EY-W, Siu K-L, Kok K-H, Lung RW-M, Tsang CM, To K-F, Kwong DL-W, Tsao SW, Jin D-Y (2008) An Epstein–Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med 205:2551–2560. CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Barth S, Pfuhl T, Mamiani A, Ehses C, Roemer K, Kremmer E, Jaker C, Hock J, Meister G, Grasser FA (2007) Epstein–Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res 36:666–675. CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Lei T, Yuen K-S, Xu R, Tsao SW, Chen H, Li M, Kok K-H, Jin D-Y (2013) Targeting of DICE1 tumor suppressor by Epstein–Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma. Int J Cancer 133:79–87. CrossRefPubMedGoogle Scholar
  25. 25.
    Kang M-S, Kieff E (2015) Epstein–Barr virus latent genes. Exp Mol Med 47:e131–e131. CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Aubry V, Mure F, Mariame B, Deschamps T, Wyrwicz LS, Manet E, Gruffat H (2014) Epstein–Barr virus late gene transcription depends on the assembly of a virus-specific preinitiation complex. J Virol 88:12825–12838. CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Hutt-Fletcher LM (2015) EBV glycoproteins: where are we now? Future Virol 10:1155–1162. CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Mackett M, Conway MJ, Arrand JR, Haddad RS, Hutt-Fletcher LM (1990) Characterization and expression of a glycoprotein encoded by the Epstein–Barr virus BamHI I fragment. J Virol 64:2545–2552PubMedPubMedCentralGoogle Scholar
  29. 29.
    Watanabe T, Tsuruoka M, Narita Y, Katsuya R, Goshima F, Kimura H, Murata T (2015) The Epstein–Barr virus BRRF2 gene product is involved in viral progeny production. Virology 484:33–40. CrossRefPubMedGoogle Scholar
  30. 30.
    Kawashima D, Kanda T, Murata T, Saito S, Sugimoto A, Narita Y, Tsurumi T (2013) Nuclear transport of Epstein–Barr virus DNA polymerase is dependent on the BMRF1 polymerase processivity factor and molecular chaperone Hsp90. J Virol 87:6482–6491. CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Tycowski KT, Guo YE, Lee N, Moss WN, Vallery TK, Xie M, Steitz JA (2015) Viral noncoding RNAs: more surprises. Genes Dev 29:567–584. CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Barabasi AL, Albert R (1999) Emergence of scaling in random networks. Science 286:509–512. CrossRefPubMedGoogle Scholar
  33. 33.
    Aittokallio T, Schwikowski B (2006) Graph-based methods for analysing networks in cell biology. Brief Bioinform 7:243–255. CrossRefGoogle Scholar
  34. 34.
    Nozawa N, Kawaguchi Y, Tanaka M, Kato A, Kato A, Kimura H, Nishiyama Y (2005) Herpes simplex virus type 1 UL51 protein is involved in maturation and egress of virus particles. J Virol 79:6947–6956. CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Do N-V, Ingemar E, Phi P-TP, Jenny A, Chinh T-T, Zeng Y, Hu L (2008) A major EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8. Virus Res 132:15–24. CrossRefPubMedGoogle Scholar
  36. 36.
    Levitskaya J, Sharipo A, Leonchiks A, Ciechanover A, Masucci MG (1997) Inhibition of ubiquitin/proteasomedependent protein degradation by the Gly-Ala repeat domain of the Epstein–Barr virus nuclear antigen 1. Proc Natl Acad Sci USA 94:12616–12621CrossRefPubMedGoogle Scholar
  37. 37.
    Gustafson EA, Chillemi AC, Sage DR, Fingeroth JD (1998) The Epstein–Barr virus thymidine kinase does not phosphorylate ganciclovir or acyclovir and demonstrates a narrow substrate specificity compared to the herpes simplex virus type 1 thymidine kinase. Antimicrob Agents Chemother 42:2923–2931CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Boccellato F, Anastasiadou E, Rosato P, Kempkes B, Frati L, Faggioni A, Trivedi P (2007) EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin’s lymphoma cells. J Virol 81:2274–2282. CrossRefPubMedGoogle Scholar
  39. 39.
    Pan S-H, Tai C-C, Lin C-S, Hsu W-B, Chou S-F, Lai C-C, Chen J-Y, Tien H-F, Lee F-Y, Wang W-B (2009) Epstein–Barr virus nuclear antigen 2 disrupts mitotic checkpoint and causes chromosomal instability. Carcinogenesis 30:366–375. CrossRefPubMedGoogle Scholar
  40. 40.
    Hickabottom M, Parker GA, Freemont P, Crook T, Allday MJ (2002) Two nonconsensus sites in the Epstein–Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP). J Biol Chem 277:47197–47204. CrossRefPubMedGoogle Scholar
  41. 41.
    Bhattacharjee S, Ghosh RS, Bose P, Saha A (2016) Role of EBNA-3 family proteins in EBV associated B-cell lymphomagenesis. Front Microbiol. CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Van Gent M, Braem SGE, de Jong A, Delagic N, Peeters JGC, Boer IGJ, Moynagh PN, Kremmer E, Wiertz EJ, Ovaa H, Griffin BD, Ressing ME (2014) Epstein–Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling. PLoS Pathog 10:e1003960. CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Association of Microbiologists of India 2018

Authors and Affiliations

  • Victor Serrano-Solis
    • 1
  • Angelica Cardoso Carlos
    • 1
  • Vinicius Maracaja-Coutinho
    • 2
    • 3
    • 4
  • Sávio Torres de Farias
    • 1
    Email author
  1. 1.Laboratório de Genética Evolutiva Paulo Leminsk, Departamento de Biologia MolecularUniversidade Federal da ParaíbaJoão PessoaBrazil
  2. 2.Advanced Center for Chronic Diseases (ACCDiS), Facultad de Ciencias Químicas y FarmacéuticasUniversidad de ChileSantiagoChile
  3. 3.Instituto VandiqueJoão PessoaBrazil
  4. 4.Beagle BioinformaticsSantiagoChile

Personalised recommendations